| Linda Uhrg Hitchcock, MD | |
|
1701 Central Ave, Ashland, KY 41101-7767 | |
| (606) 327-7759 | |
| Not Available |
| Full Name | Linda Uhrg Hitchcock |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1701 Central Ave, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639217888 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | TP890 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Linda Uhrg Hitchcock, MD 1701 Central Ave, Ashland, KY 41101-7767 Ph: (606) 327-7759 | Linda Uhrg Hitchcock, MD 1701 Central Ave, Ashland, KY 41101-7767 Ph: (606) 327-7759 |
News Archive
Noted entrepreneur and philanthropist, Tej Kohli is all set to launch Drishti Rath, a complete eye clinic on wheels. After the successful launch of the corneal blindness eradication programme in 2010, which enabled hundreds of poverty stricken corneal blind to get vision and which is still running successfully across NCR and neighbouring rural areas, Tej is set to launch this first-of-its-kind initiative in North India.
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that it was notified on November 16, 2010 by the Listing Qualifications Staff of The NASDAQ Stock Market that, due to the Company's non-compliance with the minimum $10 million stockholders' equity requirement for continued listing on The NASDAQ Global Market, as set forth in Listing Rule 5450(b)(1), the Company's common stock is subject to delisting unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel.
Mary Ann Liebert, Inc., publishers announces the launch of Disruptive Science and Technology, a highly innovative, bimonthly peer-reviewed journal that seeks to publish game-changing research that has the potential to significantly improve human health, well-being, and productivity.
Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.
› Verified 5 days ago
Hassan R Abul-khoudoud, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 Fax: 606-408-6825 | |
Larry S. Fields, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 Saint Christopher Dr, Suite 250, Ashland, KY 41101 Phone: 606-836-3196 Fax: 606-836-2564 | |
Dr. Chad Andrew Mccreary, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 Fax: 606-408-6825 | |
Robert Howard Atkins, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2201 Lexington Ave, Ashland, KY 41101 Phone: 606-408-4000 Fax: 606-408-6825 | |
Mittra Esmaeili, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 398 Diederich Blvd, Ashland, KY 41101 Phone: 606-324-8060 Fax: 606-325-6889 | |
Michael Basedow, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Ashland Dr Ste 303, Ashland, KY 41101 Phone: 606-467-2360 Fax: 606-467-2359 | |
Kristie Dickess, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1480 Carter Ave, Ashland, KY 41101 Phone: 606-329-1890 |